Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-06-04
2000-01-04
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 25, 530395, 536 64, 536 186, 5361231, A61K 3702, A61K 3736, C07K 1300
Patent
active
060110082
ABSTRACT:
A method for producing a water-soluble polysaccharide conjugate of an oxidation-sensitive substance is described. The method comprises the following steps: (a) activating the polysaccharide to a dialdehyde by periodate oxidation; (b) purifying the dialdehyde from interfering anions and by-products; and (c) coupling the substance to the purified dialdehyde by Schiff base formation to form the conjugate. Optionally, the conjugate of step (c) is reduced to an amine conjugate by a reducing substance. The product conjugate may then be further purified from various reaction byproducts. The disclosed method results in the substance substantially retaining its biological activity. Also described are imine and amine polysaccaride conjugates of various drugs and polypeptides.
REFERENCES:
patent: 4446316 (1984-05-01), Chazov et al.
patent: 4587122 (1986-05-01), Kagitani et al.
patent: 4707471 (1987-11-01), Laum
patent: 5059685 (1991-10-01), Conti
patent: 5177059 (1993-01-01), Handley et al.
patent: 5332567 (1994-07-01), Goldenberg
patent: 5393737 (1995-02-01), Mayers et al.
patent: 5567685 (1996-10-01), Linden et al.
R. Mehta et al., "Liposomal Amphotericin B is Toxic to Fungal Cells But Not to Mammalian Cells", BBA Report, 1984, pp. 230-234.
M. Maddux et al., "Review of Complicatioans of Amphotericin-B Therapy: Recommendations for Preventtion and Management", Drug Intelligence and Clinical Pharmacy, vol. 14, Mar. '80, pp. 177-181.
R. Mehta et al., "Formulation Toxicity, and Antifungal Activity in Vitro of Liposome-Encapsulated Nystatin as Therapeutic Agent for Systemic Candidasis", Antimicrob. Agents Chemero., Dec. 1987, pp. 1897-1900, vol. 31, No. 12.
M. DeGregorio et al., "Candida Infections in Patients with Acute Leukemia: Ineffectiveness of Nystatin Prophylaxis and Relationship Between Oropharyngeal and Systemic Candidiasis", Amer. Cancer Soc., Dec, 1982, vol. 50, pp. 2780-2784.
K.P. Khomyakov et al., "Synthesis of Polymeric Drugs from Dextrain Derivative Synthesis of Polymeric drugs", pp. 1145-1151.
L. Polacheck et al., "Activity of Compound G2 Isolated form Alfalfa Roots against Medically Important Yeasts", Antimicorbial Agents Chemo., Aug. '86, vol. 30, No. 2, pp. 290-294.
G. Lindenbaum et al., J. Khim-Pharm. 1977, vol. 11, No. 6, pp. 80-83.
G. Lindebaum et al., Prikl. Biochim. Mikrobiol. 1982, vol. 18, No. 2, pp. 212-220 (Russ).
G. Michael, "Nystatin", Analytical Profiles of Drugs Substances, No. 6, pp. 341-421, 1977.
Bucklin et al., Therapeutic Efficacy of Polymyxin B-Dextran 70 Conjugate in Experimental Model Endotoxemia, Jul. 1995, pp. 1462-1466.
S.W. Shalaby, ed. Biomedical polymers-Designed to degrade systems, Carl Hanser, Munich, 1994. pp. 223.
Larson, C., 1990, in Dextran Prodrugs. Physico-chemical and chemical aspects in relations to in vivo properties, Arhus. Odense. 233 p.
Levy-Shaffer, F., Berstein, A., et al., 1982, Cancer Treat. Rep., 66, 107-144.
Bornstein, A., Hurwitz, E., et al., 1978, J. Nat. Cancer Inst., 60., 379-384.
Law, S., Lo, W., & Teh. G., 1988, Drug. Dev. Ind. Pharm., 14, 143-153.
Rogovin, Z., Vymic, A., Khomyakov, K. et al., 1972, Vysokomol. Soed., 7, 1035-1040.
Hurwitz, E., et al., 1980, J. Appl. Biochem., 2, 25-35.
Stewart, J.M., Young, J.D., Solid Peptide Synthesis, Rockford, ILL., USA, Price Chem. Company, 1984, pp. 115.
Mocanu et al., Macromolecular Drug Conjugates II. Metronidaz Dextran Prodrugs, Oct. 1993, pp. 383-392.
Cera et al., Anthracycline Antiotics Supported on Water Soluable Polysaccharides: Synthesis and Psysicochemical characterization, Apr. 1988, pp. 66-74.
Manable et al., Production of a Monoclonal Antibody-Mitomycin Conjugate, Utilizing Dextran T-40, and its Biological Activit Mar. 1994, pp. 289-291.
Benita Shimon
Domb Abraham J.
Linden Galina
Polacheck Itzhack
Peselev Elli
Yissum Research Developement Company of the Hebrew University of
LandOfFree
Conjugates of biologically active substances does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugates of biologically active substances, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugates of biologically active substances will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072676